Prolonged efficacy of sotatercept in pulmonary arterial hypertension demonstrated

被引：0
|
作者：
Lichert, Frank
机构：
来源：
PNEUMOLOGIE | 2023年 / 77卷 / 07期
关键词：
D O I：
10.1055/a-2039-7782
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：402 / 402
页数：1
相关论文
共 50 条
  • [31] Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension
    Ait-Oudhia, Sihem
    Jaworowicz, David
    Hu, Ziheng
    Bihorel, Sebastien
    Hu, Shuai
    Balasubrahmanyam, Budda
    Mistry, Bipin
    Pena, Janethe de Oliveira
    Wenning, Larissa
    Gheyas, Ferdous
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2024, 13 (08): : 1380 - 1393
  • [32] Sotatercept: A First-In-Class Activin Signaling Inhibitor for Pulmonary Arterial Hypertension
    Miranda, Aimon C.
    Cornelio, Cyrille K.
    Tran, Bao Anh C.
    Fernandez, Joel
    JOURNAL OF PHARMACY TECHNOLOGY, 2025,
  • [33] Efficacy and safety of sotatercept across ranges of cardiac index in patients with pulmonary arterial hypertension: A pooled analysis of PULSAR and STELLAR
    Gomberg-Maitland, Mardi
    Badesch, David B.
    Gibbs, J. Simon R.
    Gruenig, Ekkehard
    Hoeper, Marius M.
    Humbert, Marc
    Kopec, Grzegorz
    McLaughlin, Vallerie V.
    Meyer, Gisela
    Olsson, Karen M.
    Preston, Ioana R.
    Rosenkranz, Stephan
    Souza, Rogerio
    Waxman, Aaron B.
    Perchenet, Loic
    Strait, James
    Xing, Aiwen
    Johnson-Levonas, Amy O.
    Cornell, Alexandra G.
    Pena, Janethe de Oliveira
    Ghofrani, H. Ardeschir
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2025, 44 (04): : 609 - 624
  • [34] Sotatercept for the treatment of pulmonary arterial hypertension: PULSAR open-label extension
    Humbert, Marc
    McLaughlin, Vallerie
    Gibbs, J. Simon R.
    Gomberg-Maitland, Mardi
    Hoeper, Marius M.
    Preston, Ioana R.
    Souza, Rogerio
    Waxman, Aaron B.
    Ghofrani, Hossein-Ardeschir
    Subias, Pilar Escribano
    Feldman, Jeremy
    Meyer, Gisela
    Montani, David
    Olsson, Karen M.
    Manimaran, Solaiappan
    Pena, Janethe de Oliveira
    Badesch, David B.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 61 (01)
  • [35] Sotatercept Phase 3 Program Design and Rationale: A Novel Treatment for Pulmonary Arterial Hypertension
    Preston, Ioana R.
    Badesch, David
    Ghofrani, H. A.
    Gibbs, Simon
    Gomberg-Maitland, Mardi
    Hoeper, Marius
    McLaughlin, Vallerie
    Souza, Rogerio
    Waxman, Aaron B.
    Miller, Barry
    CIRCULATION, 2021, 144
  • [36] Effects of sotatercept on lung diffusion capacity and blood gases in patients with pulmonary arterial hypertension
    Olsson, Karen M.
    Fuge, Jan
    Park, Da-Hee
    Kamp, Jan C.
    Brod, Torben
    Harrigfeld, Britta
    Schupp, Jonas C.
    Hoeper, Marius M.
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62 (02)
  • [37] PULSAR Open-Label Extension: Long-Term Efficacy and Safety of Sotatercept for the Treatment of Pulmonary Arterial Hypertension (PAH)
    Humbert, M.
    Mclaughlin, V. V.
    Gibbs, S. R.
    Gomberg-Maitland, M.
    Hoeper, M.
    Preston, I. R.
    Souza, R.
    Waxman, A. B.
    Ghofrani, H. A.
    Subias, P. Escribano
    Feldman, J. P.
    Bohns Meyer, G.
    Montani, D.
    Olsson, K. M.
    Manimaran, S.
    Pena, J. de Oliveira
    Badesch, D. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [38] Sotatercept as a next-generation therapy for pulmonary arterial hypertension: insights from the STELLAR trial
    Kopec, Grzegorz
    CARDIOVASCULAR RESEARCH, 2023, 119 (16) : E155 - E157
  • [39] Efficacy of spironolactone in pulmonary arterial hypertension
    Kubota, Kayoko
    HYPERTENSION RESEARCH, 2025, 48 (03) : 1184 - 1186
  • [40] Sotatercept: New drug on the horizon of pulmonary hypertension
    Madonna, Rosalinda
    Biondi, Filippo
    VASCULAR PHARMACOLOGY, 2024, 157
12345